SCHEMBL7043985

SCHEMBL7043985

COc1ccc(C(C)(N)c2ccc(OC)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.55
CA2 P00918 3/20 0.55
CA7 P43166 2/20 0.55
CA9 Q16790 2/20 0.55
CA12 O43570 1/20 0.55
CA14 Q9ULX7 1/20 0.55
TDP1 Q9NUW8 4/20 0.50
MAPK1 P28482 3/20 0.50
AOC3 Q16853 1/20 0.48
ALDH1A1 P00352 2/20 0.48
CYP3A4 P08684 1/20 0.48
ACHE P22303 1/20 0.46
MAPT P10636 2/20 0.46
RECQL P46063 2/20 0.44
LMNA P02545 1/20 0.44
ALOX15 P16050 1/20 0.44
APEX1 P27695 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KIF11 P52732 2/20 0.43
APP P05067 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18537263 0.91 KIF11 (0.54) CA1CA2CA7CA9CA12
SCHEMBL28770177 0.91 KIF11 (0.54) CA1CA2CA7CA9CA12
SCHEMBL3799108 0.85 CA1 (0.55) CA1CA2CA7CA9CA12
Iodide SCHEMBL25236331 0.83 CA1 (0.52) CA1CA2CA7CA9CA12
Hydrochloric Acid SCHEMBL20766163 0.83 CA1 (0.52) CA1CA2CA7CA9CA12
SCHEMBL3152160 0.82 CA1 (0.58) CA1CA2CA7CA9CA12
SCHEMBL10194078 0.82 ALDH1A1 (0.52) TDP1MAPK1AOC3ALDH1A1CYP3A4
SCHEMBL3976751 0.81 CA1 (0.50) CA1CA2CA7CA9CA12
SCHEMBL3241488 0.81 CA1 (0.50) CA1CA2CA7CA9CA12
SCHEMBL78643 0.79 MAPT (0.64) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021003295-A1 MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2021-01-07 WO disclosed
EP-2294139-B1 POLYSILOXANE-POLYCARBONATE COMPOSITIONS, METHOD OF MANUFACTURE, AND ARTICLES FORMED THEREFROM SABIC GLOBAL TECHNOLOGIES BV (NL) 2017-12-27 EP disclosed
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed